Twenty-four years of clinical practice, distilled into three principles, four phases, and a forty-two-biomarker framework that adapts as your body responds.
The CLARITY method is the clinical framework Dawn Philp, FNP-BC developed over twenty-four years of nurse-practitioner-led practice in East County San Diego. It is a continuously-adapting, biomarker-driven approach to hormone, metabolic, and longevity optimization. It is not a program, a product, or a fixed protocol. It is a methodology — a defined way of measuring, interpreting, prescribing, and re-measuring — that governs every patient's clinical pathway at THE WELLNESS CO.
This document describes the methodology: the three governing laws, the four-phase patient journey, the forty-two-biomarker measurement framework, the provider review architecture, and the tier-cadence model. Its audience is patients who want to understand the clinical logic underneath their protocol, clinicians referring patients into the practice, and anyone evaluating whether the approach fits their situation.
In 2002, Dawn Philp opened her first practice in Santee with a single treatment room. Over the following twenty-four years she treated more than 18,000 patients across hormone optimization, peptide therapy, regenerative care, and medical aesthetics.
The pattern she kept seeing — patients with "normal" labs and abnormal lives — was the seed of CLARITY. Conventional medicine reads labs against statistical averages drawn from a population that includes the sick, the sedentary, and the symptomatic. A patient whose results sit anywhere inside that statistical bell curve is told everything looks normal. The patient knows something is not normal. The lab cannot help her.
The CLARITY method emerged from refusing that framing. Each patient becomes her own reference point. Each protocol is built from her data and re-built as her data changes. The methodology is what makes that approach scale across a clinic of providers without becoming inconsistent.
A CLARITY protocol is never finished. It is re-evaluated at every cycle — typically every 8 to 12 weeks — against fresh biomarker data, symptom feedback, and the patient's evolving goals. The protocol adapts. Dosage, delivery form, supporting agents, lifestyle prescriptions are all subject to re-calibration.
The reason most patients fail on conventional hormone or peptide therapy is not the molecule. It is the absence of monitoring. A correct prescription becomes wrong as the body responds to it. Without re-testing, no one notices. Under the first law of CLARITY, re-testing is the default and adjustment is the expectation.
Patients do not advance to deeper or more aggressive optimization until their biomarkers earn it. Labs uncover the picture, labs gate progression to the next phase of protocol, and labs validate outcomes before any further escalation. Symptoms inform the conversation. They do not override the data.
This law is what protects patients from the most common failure modes of optimization medicine — overprescription, stacking interventions before their effects can be measured, and chasing symptoms across body systems without an objective anchor.
Every CLARITY patient receives the same clinical methodology. The membership tier — Core, Elite, or Transformation — governs how often Dawn personally reviews the case, how detailed the adaptive protocol updates are, and how frequently the patient is re-tested.
No patient is denied a clinical pathway because of tier. A Core member's lab panel is read by the same provider as a Transformation member's. The tier sets the cadence of provider review and the depth of the adaptive infrastructure around that review — not whether the methodology applies.
Comprehensive baseline mapping. Forty-two biomarkers across ten body systems. Pattern identification by clinical review — not symptom checklist, not algorithmic readout.
The first cycle of protocol — typically 8 to 12 weeks. Initial dosing, lifestyle calibration, monitoring of safety markers. Most patients notice change inside this phase.
Mid-program adjustments based on response data. Re-tested labs guide dose changes, form switches, addition or removal of supporting protocols.
Long-term cadence once initial optimization is stable. Re-testing every six months minimum. Protocol continues to adapt as life, age, and circumstances change.
CLARITY's baseline panel is broader than a conventional annual physical (10-15 markers) and intentionally cross-system. Pattern recognition lives in the relationships between markers, not any single value.
Baseline. At intake, the full 42-marker panel is drawn. Dawn personally reviews every panel and generates the CLARITY Diagnostic Report — a cross-system pattern interpretation. The first protocol is built from this baseline.
8 to 12 weeks. The patient returns for follow-up labs. The re-tested panel is read against the baseline. Dawn evaluates: are the target markers moving in the expected direction? Are safety markers (hematocrit on TRT, estradiol conversion, hepatic markers) staying inside safe range? Are unexpected patterns emerging in adjacent systems?
Adjustment. Based on the re-test interpretation, the protocol is adjusted. The adjustment may be dose, delivery form, addition of a supporting agent (e.g., HCG alongside testosterone), removal of an intervention that has done its work, or a new lifestyle prescription.
Repeat. The cycle continues. In the Maintain & Evolve phase, the re-test cadence stretches to every six months minimum — sooner if symptoms change, life circumstances shift, or new clinical concerns surface.
Per the Third Law, every patient receives the same clinical methodology. What changes is the cadence at which Dawn personally reviews the case and the depth of the adaptive infrastructure around it.
Every commercial service at THE WELLNESS CO. is delivered through the CLARITY method. The methodology is the why; these are the where.
BHRT and TRT calibrated to your biomarker baseline and adjusted every 8-12 weeks. The clearest expression of the Three Laws.
See hormone therapy →17+ peptide stacks selected from your biomarker profile and goals. Re-tested at every cycle to track response and adjust dosing.
See peptide therapy →Root-cause metabolic protocols built on your fasting insulin, HbA1c, and hormone panel. We do not prescribe GLP-1 medications — the methodology addresses the underlying drivers (insulin resistance, hormone decline, thyroid dysfunction) rather than appetite suppression alone.
See weight management →Nutrient and IV protocols matched to documented depletions from the baseline panel. Re-evaluated at each follow-up.
See IV therapy →Thermal imaging that integrates with the CLARITY panel for inflammation mapping and longitudinal monitoring.
See thermography →The day-by-day patient experience of CLARITY: consultation, lab interpretation, deep-dive optimization visit.
See the process →The CLARITY method is a synthesis — not a peer-reviewed publication. Its individual clinical principles are each supported by published literature. Selected references:
References are illustrative of the methodology's clinical basis and do not constitute endorsements. Patients evaluating CLARITY for their own care should discuss the literature with their provider.
The CLARITY method is the clinical methodology Dawn Philp, FNP-BC developed over 24 years of practice. It is a biomarker-driven, continuously-adapting framework for hormone, metabolic, and longevity optimization. Three principles govern it: no static prescription, data-earned progression, and membership tiers governing the cadence of provider review — not access to care.
Most functional medicine practices test extensively at baseline, prescribe a protocol, and adjust at long intervals — often annually. CLARITY re-tests every 8 to 12 weeks and adjusts the protocol against your individual data each cycle. The protocol evolves with the patient. It does not get filed and forgotten.
Forty-two biomarkers across ten body systems: hormone, thyroid, adrenal, metabolic, inflammation, nutrient, cardiovascular, liver, immune, and blood cell. The full diagnostic panel is reviewed personally by Dawn for every patient, regardless of membership tier.
Because pattern recognition across the full hormonal-metabolic-adrenal picture is a clinical interpretation, not a numeric readout. Dawn has reviewed thousands of these panels and can recognize patterns that any individual marker would miss. Review is the gating step before any protocol is written.
Every CLARITY patient — Core, Elite, or Transformation — gets the same clinical methodology. The tier governs how often Dawn personally reviews their case (quarterly, monthly, or continuously) and how detailed the adaptive protocol updates are. No patient is denied a clinical pathway because of their tier.
Understand (baseline biomarker mapping and pattern identification), Stabilize (the first cycle of protocol — typically 8-12 weeks), Optimize (mid-program adjustments based on response data), and Maintain & Evolve (long-term cadence once initial optimization is stable).
The CLARITY methodology is a clinical framework, not a peer-reviewed publication. The clinical principles it rests on — biomarker-driven dosing, continuous monitoring of hormone replacement, individual reference ranges over population averages — are each supported by peer-reviewed literature (see the Clinical Basis section above). The methodology is the way Dawn synthesizes those principles into a continuously-adapting protocol.
Upload your recent bloodwork and Dawn's clinical team will interpret it through the CLARITY framework — completely free.
Get Your Free Lab Review →Forty-two biomarkers. One clinical interpretation. A protocol that adapts as you do.
Book Your Consultation